SenesTech, Inc. Common Stock
SNESSenesTech, Inc. (SNES) is a biotechnology company that develops and commercializes products aimed at managing pest populations through reproductive control. The company is best known for its innovative use of reproductive suppression technology to address pest-related challenges in agriculture, urban settings, and beyond. Its flagship product, ContraPest, is designed to effectively reduce rodent populations by targeting their fertility, offering an environmentally friendly and humane alternative to traditional pest control methods.
Company News
SenesTech reported record quarterly revenue of $690,000, a 43% increase from the previous year, with Evolve® Rodent Birth Control product sales growing 77% and representing 85% of total revenue. The company continues to expand across e-commerce, municipal, and retail markets while maintaining a strong cash balance of $10.2 million.
SenesTech completed a warrant exercise transaction, raising approximately $6.3 million in gross proceeds through the issuance of new short-term warrants. The company plans to use the funds for working capital and general corporate purposes.
SenesTech, a company specializing in fertility control for animal pest populations, will release its Q2 2025 financial results on August 7, 2025, after market close, with a conference call scheduled for 5:00 p.m. Eastern time.
SenesTech, a pioneer in fertility control solutions for managing rodent populations, announced its participation in the Lytham Partners Spring 2025 Investor Conference, where it will present a webcast and host one-on-one meetings with investors.
SenesTech reported strong Q4 2024 financial results, including 70% revenue growth, 61% gross profit margins, and reduced operating expenses. The company also announced new optimization initiatives to further reduce expenses and accelerate its path to profitability.
